Matches in SemOpenAlex for { <https://semopenalex.org/work/W2141569219> ?p ?o ?g. }
- W2141569219 endingPage "483" @default.
- W2141569219 startingPage "479" @default.
- W2141569219 abstract "Objectives . To analyse the prevalence of α-fodrin antibodies in patients with primary (pSS) and secondary Sjögren's syndrome (sSS) and the relation to clinical, serological and immunological features. Methods . Serum IgA and IgG antibodies to the 120 kDa α-fodrin were determined by ELISA technique in 62 pSS patients and 28 sSS patients. Results were correlated with clinical symptoms and laboratory findings as well as with the HLA-DR genotype. Additionally, antibody concentrations were correlated with the numbers of peripheral blood mononuclear cells (PBMCs) secreting interleukin (IL)-6, IL-10, interferon-γ (INF)-γ, and tumour necrosis factor-α determined by ELISPOT analysis. Lymphocytes and monocytes were examined flow-cytometrically for the expression of activation markers. Healthy age- and sex-matched volunteers served as controls. Results . The sensitivity of IgA and IgG α-fodrin antibodies was 35 and 31%, respectively, in pSS patients. In sSS patients, the sensitivity was 29 and 21%, respectively. In pSS patients with IgG antibodies, recurrent parotid swelling was significantly more prevalent. Also the number of INF-γ secreting PBMCs and the percentage of CD4/CD71+ lymphocytes as well as CD14/HLA-DR+ monocytes were significantly increased in this group compared with α-fodrin-negative patients or with controls. Interestingly, these patients also had a shorter disease duration. No association of α-fodrin antibodies with the HLA-DR genotype was found. Conclusion . Due to the low prevalence, serum antibodies to α-fodrin turned out to be of limited diagnostic value in our study. However, our data suggest that IgG antibodies to α-fodrin are indicative of clinical and immunological activity in pSS especially in patients with shorter disease duration and may thus serve as a marker of disease activity." @default.
- W2141569219 created "2016-06-24" @default.
- W2141569219 creator A5033193879 @default.
- W2141569219 creator A5037057775 @default.
- W2141569219 creator A5063217477 @default.
- W2141569219 creator A5067524722 @default.
- W2141569219 creator A5067841113 @default.
- W2141569219 creator A5081872257 @default.
- W2141569219 creator A5082302773 @default.
- W2141569219 date "2007-01-25" @default.
- W2141569219 modified "2023-10-04" @default.
- W2141569219 title "Clinical and immunological characteristics of patients with Sjogren's syndrome in relation to -fodrin antibodies" @default.
- W2141569219 cites W1509336549 @default.
- W2141569219 cites W1534164957 @default.
- W2141569219 cites W1675238122 @default.
- W2141569219 cites W1831057112 @default.
- W2141569219 cites W1995029669 @default.
- W2141569219 cites W2001047384 @default.
- W2141569219 cites W2005486632 @default.
- W2141569219 cites W2005760600 @default.
- W2141569219 cites W2017922895 @default.
- W2141569219 cites W2018967405 @default.
- W2141569219 cites W2024383929 @default.
- W2141569219 cites W2052379183 @default.
- W2141569219 cites W2066260829 @default.
- W2141569219 cites W2070527591 @default.
- W2141569219 cites W2078384109 @default.
- W2141569219 cites W2081446915 @default.
- W2141569219 cites W2090497409 @default.
- W2141569219 cites W2091583666 @default.
- W2141569219 cites W2099096078 @default.
- W2141569219 cites W2111631948 @default.
- W2141569219 cites W2122102427 @default.
- W2141569219 cites W2125207378 @default.
- W2141569219 cites W2133550995 @default.
- W2141569219 cites W2142664470 @default.
- W2141569219 cites W2152348310 @default.
- W2141569219 cites W2167385753 @default.
- W2141569219 cites W2400642184 @default.
- W2141569219 cites W2461027874 @default.
- W2141569219 cites W2471958312 @default.
- W2141569219 cites W46650105 @default.
- W2141569219 doi "https://doi.org/10.1093/rheumatology/kel270" @default.
- W2141569219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16935916" @default.
- W2141569219 hasPublicationYear "2007" @default.
- W2141569219 type Work @default.
- W2141569219 sameAs 2141569219 @default.
- W2141569219 citedByCount "26" @default.
- W2141569219 countsByYear W21415692192012 @default.
- W2141569219 countsByYear W21415692192014 @default.
- W2141569219 countsByYear W21415692192016 @default.
- W2141569219 countsByYear W21415692192017 @default.
- W2141569219 countsByYear W21415692192018 @default.
- W2141569219 countsByYear W21415692192021 @default.
- W2141569219 countsByYear W21415692192022 @default.
- W2141569219 crossrefType "journal-article" @default.
- W2141569219 hasAuthorship W2141569219A5033193879 @default.
- W2141569219 hasAuthorship W2141569219A5037057775 @default.
- W2141569219 hasAuthorship W2141569219A5063217477 @default.
- W2141569219 hasAuthorship W2141569219A5067524722 @default.
- W2141569219 hasAuthorship W2141569219A5067841113 @default.
- W2141569219 hasAuthorship W2141569219A5081872257 @default.
- W2141569219 hasAuthorship W2141569219A5082302773 @default.
- W2141569219 hasBestOaLocation W21415692191 @default.
- W2141569219 hasConcept C137061746 @default.
- W2141569219 hasConcept C159654299 @default.
- W2141569219 hasConcept C202751555 @default.
- W2141569219 hasConcept C203014093 @default.
- W2141569219 hasConcept C2778513237 @default.
- W2141569219 hasConcept C45189115 @default.
- W2141569219 hasConcept C553184892 @default.
- W2141569219 hasConcept C55493867 @default.
- W2141569219 hasConcept C71924100 @default.
- W2141569219 hasConcept C86803240 @default.
- W2141569219 hasConceptScore W2141569219C137061746 @default.
- W2141569219 hasConceptScore W2141569219C159654299 @default.
- W2141569219 hasConceptScore W2141569219C202751555 @default.
- W2141569219 hasConceptScore W2141569219C203014093 @default.
- W2141569219 hasConceptScore W2141569219C2778513237 @default.
- W2141569219 hasConceptScore W2141569219C45189115 @default.
- W2141569219 hasConceptScore W2141569219C553184892 @default.
- W2141569219 hasConceptScore W2141569219C55493867 @default.
- W2141569219 hasConceptScore W2141569219C71924100 @default.
- W2141569219 hasConceptScore W2141569219C86803240 @default.
- W2141569219 hasIssue "3" @default.
- W2141569219 hasLocation W21415692191 @default.
- W2141569219 hasLocation W21415692192 @default.
- W2141569219 hasOpenAccess W2141569219 @default.
- W2141569219 hasPrimaryLocation W21415692191 @default.
- W2141569219 hasRelatedWork W2016526094 @default.
- W2141569219 hasRelatedWork W2096525231 @default.
- W2141569219 hasRelatedWork W2262225542 @default.
- W2141569219 hasRelatedWork W2351611371 @default.
- W2141569219 hasRelatedWork W2370879936 @default.
- W2141569219 hasRelatedWork W2380076873 @default.
- W2141569219 hasRelatedWork W2381795296 @default.
- W2141569219 hasRelatedWork W3150953239 @default.
- W2141569219 hasRelatedWork W3200600991 @default.